Rachel Segal, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 326 Matawan Ave Apt A, Cliffwood, NJ 07721 Phone: 732-970-7569 |
News Archive
Sigma-Aldrich (Nasdaq: SIAL) today announced an agreement with Glycosan BioSystems for the sale of HyStem(TM), a fully customizable synthetic extracellular matrix (ECM) for stem cell research. HyStem offers researchers flexibility to tailor microenvironments for their cultured cells that mimic natural in vivo conditions, optimizing stem cell proliferation and differentiation. HyStem was developed by Glycosan BioSystems and will be sold by Sigma-Aldrich under a non-exclusive distribution agreement.
Such a harmless and common object in our society represents a real problem for four in ten young adults in Spain, for whom their mobile phone has turned into an addiction that can lead them to consequences as dangerous as those caused by alcohol or drugs.
Whether the federal program should pay the same for a treatment whether the patient gets it at a doctor's office or, say, an outpatient hospital facility, was the focus of a congressional hearing.
Italian scientists suggest that we need a much more detailed toxicological approach to hazard assessment before judgement regarding the long-term safety of carbon nanotubes can be made. They outline their results in the International Journal of Environment and Health.
› Verified 5 days ago